基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the detailed record of transactions filed by Woods Lori A, 董事长兼首席执行官. Director active across 2 companies, notably Isoray, Inc.. Aggregated, 8 disclosures have been recorded. Split: 6 buys · 0 sell. Total volume traded: €199k. History available since 23 November 2021. The latest transaction was disclosed on 31 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Woods Lori A is President-Director General and has filed 8 forms in total. Across the 8 sampled filings, the buy transactions amount to EUR 199041 and no sales are indicated, with activity observed from 2021-11-24 to 2025-04-01. The companies mentioned in the filings are Perspective Therapeutics, Inc. and Isoray, Inc.